Self-cascade nanohybrids boost cell ferroptosis stress for tumor radiosensitization therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (81)
Show source-provided references
1. Improving radiotherapy in cancer treatment: promises and challenges10.18632/oncotarget.18409 ↗
2. Emerging strategies of nanomaterial-mediated tumor radiosensitization10.1002/adma.201802244 ↗
3. A biomimetic nanozyme/camptothecin hybrid system for synergistically enhanced radiotherapy10.1039/D0TB00676A ↗
4. Au-hemoglobin loaded platelet alleviating tumor hypoxia and enhancing the radiotherapy effect with low-dose X-ray10.1021/acsnano.0c06541 ↗
5. Glutathione-depleting gold nanoclusters for enhanced cancer radiotherapy through synergistic external and internal regulations10.1021/acsami.8b00207 ↗
6. Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma10.1039/C4NR03693J ↗
7. Stable black phosphorus/Bi2O3 heterostructures for synergistic cancer radiotherapy10.1016/j.biomaterials.2018.04.022 ↗
8. Targeted gold nanocluster-enhanced radiotherapy of prostate cancer10.1002/smll.201900968 ↗
9. Photosynthetic biohybrid nanoswimmers system to alleviate tumor hypoxia for FL/PA/MR imaging-guided enhanced radio-photodynamic synergetic therapy
10. Overcoming hypoxia-restrained radiotherapy using an erythrocyte-inspired and glucose-activatable platform10.1021/acs.nanolett.0c00650 ↗
11. Unveiling the active sites on ferrihydrite with apparent catalase-like activity for potentiating radiotherapy10.1016/j.nantod.2021.101317 ↗
12. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
13. Multidrug resistance in cancer: role of ATP-dependent transporters10.1038/nrc706 ↗
14. IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer10.1038/nrc2889 ↗
15. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer10.1038/nature11156 ↗
16. Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer10.1016/j.jtbi.2015.10.019 ↗
17. Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis
18. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression10.1038/s41422-019-0263-3 ↗
19. Targeting ferroptosis to iron out cancer10.1016/j.ccell.2019.04.002 ↗
20. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease10.1016/j.cell.2017.09.021 ↗
21. Nanozymes: a clear definition with fuzzy edges10.1016/j.nantod.2021.101269 ↗
22. Nanozymes inspired by natural enzymes10.1021/accountsmr.1c00074 ↗
23. Nanozyme for tumor therapy: surface modification matters10.1002/EXP.20210005 ↗
24. Emerging strategies of cancer therapy based on ferroptosis
25. Boosting the ferroptotic antitumor efficacy via site-specific amplification of tailored lipid peroxidation10.1021/acsami.9b10954 ↗
26. BHQ-cyanine-based "off-on" long-circulating assembly as a ferroptosis amplifier for cancer treatment: a lipid-peroxidation burst device10.1021/acsami.9b12469 ↗
27. Redox responsive metal organic framework nanoparticles induces ferroptosis for cancer therapy10.1002/smll.202001251 ↗
28. Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO3 nanoformulation triggers ferroptosis in target tumor cells10.1126/sciadv.aax1346 ↗
29. NIR-actuated remote activation of ferroptosis in target tumor cells through a photothermally responsive iron-chelated biopolymer nanoplatform10.1002/anie.202016872 ↗
30. Production of large amounts of hydrogen peroxide by human tumor cells
31. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy10.1039/C7CS00471K ↗
32. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy10.1021/jacs.9b03457 ↗
33. An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion10.1021/acs.nanolett.8b03178 ↗
34. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction10.1002/anie.201510031 ↗
35. H2O2 self-producing single-atom nanozyme hydrogels as light-controlled oxidative stress amplifier for enhanced synergistic therapy by transforming “cold” tumors10.1002/adfm.202110268 ↗
36. Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy10.1021/acsnano.9b07789 ↗
37. High-performance self-cascade pyrite nanozymes for apoptosis-ferroptosis synergistic tumor therapy10.1021/acsnano.1c01248 ↗
38. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment10.1039/C7CS00891K ↗
39. Co–ferrocene MOF/glucose oxidase as cascade nanozyme for effective tumor therapy10.1002/adfm.201910085 ↗
40. Nanozymes-engineered metal-organic frameworks for catalytic cascades-enhanced synergistic cancer therapy10.1021/acs.nanolett.9b02253 ↗
41. Biomimetic CoO@AuPt nanozyme responsive to multiple tumor microenvironmental clues for augmenting chemodynamic therapy10.1016/j.biomaterials.2020.120279 ↗
42. MnO2 motor: a prospective cancer-starving therapy promoter10.1021/acsami.8b01818 ↗
43. Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation10.1021/acsnano.8b05042 ↗
44. Glucose Oxidase-instructed multimodal synergistic cancer therapy10.1002/adma.201808325 ↗
45. Manganese oxide nanomaterials: synthesis, properties, and theranostic applications10.1002/adma.201905823 ↗
46. MnO2-laden black phosphorus for MRI-guided synergistic PDT, PTT, and chemotherapy10.1016/j.matt.2019.03.007 ↗
47. Intelligent albumin-MnO2 nanoparticles as pH-/H2O2-responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy10.1002/adma.201601902 ↗
48. A smart photosensitizer–manganese dioxide nanosystem for enhanced photodynamic therapy by reducing glutathione levels in cancer cells10.1002/anie.201510748 ↗
49. Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer10.1002/adma.201402572 ↗
50. Biomimetic nanoflowers by self-assembly of nanozymes to induce intracellular oxidative damage against hypoxic tumors10.1038/s41467-018-05798-x ↗
51. Protein-directed metal oxide nanoflakes with tandem enzyme-like characteristics: colorimetric glucose sensing based on one-pot enzyme-free cascade catalysis10.1002/adfm.201800018 ↗
52. Wet/sono-chemical synthesis of enzymatic two-dimensional MnO2 nanosheets for synergistic catalysis-enhanced phototheranostics10.1002/adma.201900401 ↗
53. Ultrasmall Au(10-12)(SG)(10-12) nanomolecules for high tumor specificity and cancer radiotherapy10.1002/adma.201400866 ↗
54. RGD peptide-modified fluorescent gold nanoclusters as highly efficient tumor-targeted radiotherapy sensitizers10.1016/j.biomaterials.2017.08.017 ↗
55. Protein-directed synthesis of highly fluorescent gold nanoclusters10.1021/ja806804u ↗
56. Mimicking drug-substrate interaction: a smart bioinspired technology for the fabrication of theranostic nanoprobes10.1002/adfm.201603440 ↗
57. Enhanced tumor accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy10.1002/adhm.201300189 ↗
58. Cisplatin prodrug-conjugated gold nanocluster for fluorescence imaging and targeted therapy of the breast cancer10.7150/thno.14556 ↗
59. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics10.1021/acsnano.8b06399 ↗
60. Immunomodulation-enhanced nanozyme-based tumor catalytic therapy10.1002/adma.202003563 ↗
61. The catalytic activity of "Naked" gold particles10.1002/ange.200460446 ↗
62. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
63. BSA-stabilized Au clusters as peroxidase mimetics for use in xanthine detection10.1016/j.bios.2011.02.014 ↗
64. Nano-gold as artificial enzymes: hidden talents10.1002/adma.201400238 ↗
65. Copper(II)-graphitic carbon nitride triggered synergy: improved ROS generation and reduced glutathione levels for enhanced photodynamic therapy10.1002/anie.201605509 ↗
66. Polyoxometalate-based radiosensitization platform for treating hypoxic tumors by attenuating radioresistance and enhancing radiation response10.1021/acsnano.7b03037 ↗
67. Simultaneous Fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy10.1002/ange.201712027 ↗
68. A methodology for analysis of tissue sulfhydryl components10.1016/0003-2697(72)90335-1 ↗
69. A precise method for the determination of whole blood and plasma sulfhydryl groups10.1016/S0003-2697(79)80122-0 ↗
70. Metabolic control by heat stress determining cell fate to ferroptosis for effective cancer therapy10.1021/acsnano.1c00380 ↗
71. Biodegradable biomimic copper/manganese silicate nanospheres for chemodynamic/photodynamic synergistic therapy with simultaneous glutathione depletion and hypoxia relief10.1021/acsnano.8b09387 ↗
72. Tumor microenvironment-responsive mesoporous MnO2-coated upconversion nanoplatform for self-enhanced tumor theranostics10.1002/adfm.201803804 ↗
73. Cancer metabolism: looking forward10.1038/s41568-021-00378-6 ↗
74. Cancer metabolism: current understanding and therapies10.1021/acs.chemrev.7b00775 ↗
75. Switching apoptosis to ferroptosis: metal-organic network for high-efficiency anticancer therapy10.1021/acs.nanolett.6b04060 ↗
76. EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: from animal to human with theranostic AGuIX nanoparticles10.7150/thno.37543 ↗
77. Renal clearable noble metal nanoparticles: photoluminescence, elimination, and biomedical applications10.1002/wnan.1453 ↗
78. Imaging nano-bio interactions in the kidney: toward a better understanding of nanoparticle clearance10.1002/anie.201711705 ↗
79. Physiological stability and renal clearance of ultrasmall zwitterionic gold nanoparticles: ligand length matters10.1063/1.4978381 ↗
80. Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance10.1021/ja401612x ↗
81. Luminescent gold nanoparticles with efficient renal clearance10.1002/anie.201007321 ↗